Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

Hypertension control is critical to prevent stroke. With several clinical trials conducted over the last decade, it seems that the use of an angiotensin-modulating antihypertensive agent conveys ...

Please provide your email address to receive an email when new articles are posted on . Angiotensin receptor blockers were linked to worse outcomes in patients with celiac disease. Patients exhibited ...

Background Hypertension is highly prevalent among patients with chronic kidney disease (CKD) and contributes substantially to ...

First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses. Comparative diagnostic accuracy and tumor ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...

A class of drugs already on the market to lower blood pressure appears to reduce adults' risk of developing epilepsy, Stanford Medicine researchers and their colleagues have discovered. The finding ...

Researchers found that the incidence of epilepsy was reduced with use of ARBs vs ACEs, β-blockers, and a combination of other antihypertensive classes. HealthDay News — For patients with hypertension, ...

Three large randomized trials tested a simple idea: if one blood-pressure drug that blocks the renin-angiotensin system ...

Associations of postdiagnosis changes in physical activity with all-cause mortality among patients with stage I-IIA colorectal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...